HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukito Ichinose Selected Research

Tegafur

11/2013Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.
5/2010A multi-institution phase I/II trial of triweekly regimen with S-1 plus cisplatin in patients with advanced non-small cell lung cancer.
6/2008Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.
12/2006[Adjuvant chemotherapy for non-small cell lung cancer].
6/2005[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
12/2004S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.
7/2004Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial.
4/2004A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
12/2003Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukito Ichinose Research Topics

Disease

76Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019 - 04/2002
29Neoplasms (Cancer)
06/2018 - 04/2002
18Adenocarcinoma
01/2018 - 04/2004
17Lung Neoplasms (Lung Cancer)
05/2019 - 05/2002
9Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2015 - 09/2002
7Malignant Mesothelioma
06/2018 - 05/2004
6Diarrhea
05/2019 - 11/2006
6Neoplasm Metastasis (Metastasis)
04/2018 - 02/2003
5Neutropenia
05/2019 - 11/2006
5Febrile Neutropenia
05/2019 - 11/2006
5Disease Progression
10/2014 - 04/2006
4Thymoma (Thymic Carcinoma)
04/2016 - 01/2006
4Adenocarcinoma of Lung
05/2014 - 08/2005
4Interstitial Lung Diseases (Interstitial Lung Disease)
11/2011 - 06/2008
3Lymphatic Metastasis
04/2018 - 02/2004
3Leukopenia
01/2017 - 07/2010
3Lymphoma (Lymphomas)
08/2015 - 01/2010
3Exanthema (Rash)
09/2013 - 09/2009
2Pleural Effusion (Pleural Effusions)
12/2017 - 03/2014
2Carcinogenesis
09/2016 - 09/2013
2Infections
01/2016 - 11/2006
2Acne Vulgaris
09/2013 - 09/2009
2Pneumonia (Pneumonitis)
09/2008 - 05/2008
2Drug-Related Side Effects and Adverse Reactions
07/2008 - 11/2005
2Residual Neoplasm
10/2007 - 04/2002
2Adenoid Cystic Carcinoma (Cylindroma)
02/2006 - 04/2002
2Pleurisy (Pleuritis)
06/2004 - 04/2002
1Small Cell Carcinoma
01/2018
1Weight Loss (Weight Reduction)
11/2017
1Hypertension (High Blood Pressure)
11/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2016
1Malignant Pleural Effusion
06/2015
1Adenosquamous Carcinoma
02/2014

Drug/Important Bio-Agent (IBA)

30Cisplatin (Platino)FDA LinkGeneric
01/2018 - 04/2002
19ErbB Receptors (EGF Receptor)IBA
05/2019 - 06/2005
17Gefitinib (Iressa)FDA Link
05/2019 - 06/2005
10Carboplatin (JM8)FDA LinkGeneric
01/2018 - 02/2008
9PlatinumIBA
05/2019 - 06/2008
9Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 02/2008
9TegafurIBA
11/2013 - 12/2003
8GemcitabineFDA Link
01/2018 - 08/2005
8Tyrosine Kinase InhibitorsIBA
01/2017 - 10/2005
7Docetaxel (Taxotere)FDA Link
05/2019 - 09/2002
7Vinorelbine (Navelbine)FDA LinkGeneric
01/2018 - 08/2005
6Irinotecan (Camptosar)FDA LinkGeneric
01/2017 - 09/2002
6UracilIBA
06/2008 - 12/2003
5Bevacizumab (Avastin)FDA Link
05/2019 - 06/2012
5Pemetrexed (MTA)FDA Link
01/2019 - 05/2008
5S-1 plus cisplatinIBA
01/2018 - 12/2004
5Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2017 - 02/2010
4Anaplastic Lymphoma KinaseIBA
12/2017 - 09/2013
4Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
08/2015 - 01/2010
4Phosphotransferases (Kinase)IBA
08/2015 - 07/2006
4amrubicinIBA
04/2014 - 01/2006
4Pharmaceutical PreparationsIBA
10/2013 - 05/2008
4Vindesine (Vindesin)IBA
02/2008 - 02/2003
3CrizotinibIBA
01/2017 - 11/2013
3Carcinoembryonic AntigenIBA
01/2016 - 06/2005
3Fluorouracil (Carac)FDA LinkGeneric
11/2013 - 06/2006
3potassium oxonateIBA
05/2010 - 12/2004
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2005 - 06/2005
2AfatinibIBA
04/2018 - 09/2013
2130-nm albumin-bound paclitaxelIBA
01/2018 - 07/2013
2motesanib diphosphateIBA
11/2017 - 08/2012
2Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 12/2004
2ceritinibIBA
12/2015 - 07/2015
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2012 - 07/2006
2DNA (Deoxyribonucleic Acid)IBA
01/2012 - 09/2011
2Topotecan (Hycamtin)FDA LinkGeneric
10/2011 - 02/2011
2titanium silicide (TS-1)IBA
08/2010 - 04/2006
2Hemoglobins (Hemoglobin)IBA
06/2010 - 05/2008
2Etoposide (VP 16)FDA LinkGeneric
11/2006 - 05/2005
1AlbuminsIBA
06/2018
1C-Reactive ProteinIBA
06/2018
1alpha-galactosylceramideIBA
01/2017
1EnzymesIBA
09/2016
1Sunitinib (Sutent)FDA Link
04/2016
1Anti-Infective Agents (Microbicides)IBA
04/2016
1Meropenem (Merrem)FDA LinkGeneric
04/2016
1Cefepime (Maxipime)FDA LinkGeneric
04/2016
1Imatinib Mesylate (Gleevec)FDA Link
04/2016
1Estrogen ReceptorsIBA
01/2016
1alectinibIBA
12/2015
1Biomarkers (Surrogate Marker)IBA
12/2015
1Epidermal Growth Factor (EGF)IBA
07/2014
1Topoisomerase II InhibitorsIBA
04/2014
1Anti-Bacterial Agents (Antibiotics)IBA
03/2014

Therapy/Procedure

35Drug Therapy (Chemotherapy)
05/2019 - 02/2004
20Therapeutics
05/2019 - 02/2003
16Radiotherapy
01/2018 - 04/2002
13Chemoradiotherapy
03/2019 - 09/2002
10Adjuvant Chemotherapy
01/2017 - 02/2004
8Combination Drug Therapy (Combination Chemotherapy)
05/2019 - 12/2003
6Pneumonectomy (Lung Volume Reduction)
03/2019 - 05/2004
3Thoracotomy
08/2005 - 04/2002
2Immunotherapy
01/2017 - 08/2013
1Lymph Node Excision (Lymph Node Dissection)
12/2017
1Molecular Targeted Therapy
04/2016
1Metastasectomy
01/2016
1Segmental Mastectomy (Lumpectomy)
02/2014